Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients

OBJECTIVE: This study aimed to investigate the correlation of serum Jun-amino-terminal kinase (JNK) pathway-associated phosphatase (JKAP) level with disease risk, severity, inflammation, and treatment response to tumor necrosis factor (TNF)-α inhibitor in Crohn disease (CD) patients. METHOD: Ninety-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xue, Yang, Wei, Wang, Nian, Zhu, Junyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831387/
https://www.ncbi.nlm.nih.gov/pubmed/31415355
http://dx.doi.org/10.1097/MD.0000000000016622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831387/
https://www.ncbi.nlm.nih.gov/pubmed/31415355
http://dx.doi.org/10.1097/MD.0000000000016622

Ejemplares similares